The Guy's Neurological Disability Scale in patients with multiple sclerosis: a clinical evaluation of its reliability and validity. (Q52014516)

19 April 2018

title

The Guy's Neurological Disability Scale in patients with multiple sclerosis: a clinical evaluation of its reliability and validity. (English)

1 reference

19 April 2018

0 references

0 references

2

Derick T Wade

1 reference

19 April 2018

author name string

Philippe Rossier

series ordinal

1

1 reference

19 April 2018

publication date

1 February 2002

1 reference

19 April 2018

published in

Clinical Rehabilitation

1 reference

19 April 2018

volume

16

1 reference

19 April 2018

issue

1

1 reference

19 April 2018

page(s)

75-95

1 reference

19 April 2018

The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group

cites work

1 reference

https://api.crossref.org/works/10.1191%2F0269215502CR447OA

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215502CR447OA

Recent advances in rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215502CR447OA

Development of a multiple sclerosis functional composite as a clinical trial outcome measure

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215502CR447OA

Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215502CR447OA

Reliability of distance estimation by doctors and patients: cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215502CR447OA

Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215502CR447OA

Quality of life in multiple sclerosis: the disability and impact profile (DIP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215502CR447OA

Validation of the functional assessment of multiple sclerosis quality of life instrument

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215502CR447OA

Validation of Italian multiple sclerosis quality of life 54 questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215502CR447OA

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215502CR447OA

The Barthel ADL Index: a standard measure of physical disability?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215502CR447OA

The Rivermead Mobility Index: a further development of the Rivermead Motor Assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215502CR447OA

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215502CR447OA

Validation of the 3-oz water swallow test for aspiration following stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215502CR447OA

Statistical methods for assessing agreement between two methods of clinical measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269215502CR447OA

10.1191/0269215502CR447OA

21 January 2018

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018